Clorox Balance Sheet Health
Financial Health criteria checks 2/6
Clorox has a total shareholder equity of $224.0M and total debt of $2.5B, which brings its debt-to-equity ratio to 1109.8%. Its total assets and total liabilities are $5.5B and $5.3B respectively. Clorox's EBIT is $1.2B making its interest coverage ratio 17.2. It has cash and short-term investments of $278.0M.
Key information
1,109.8%
Debt to equity ratio
US$2.49b
Debt
| Interest coverage ratio | 17.2x |
| Cash | US$278.00m |
| Equity | US$224.00m |
| Total liabilities | US$5.27b |
| Total assets | US$5.50b |
Recent financial health updates
We Think Clorox (NYSE:CLX) Can Manage Its Debt With Ease
Dec 24
Is Clorox (NYSE:CLX) A Risky Investment?
May 25Is Clorox (NYSE:CLX) Using Too Much Debt?
Feb 09Recent updates
We Think Clorox (NYSE:CLX) Can Manage Its Debt With Ease
Dec 24Return Trends At Clorox (NYSE:CLX) Aren't Appealing
Dec 02The Clorox Company: Hold, Trading Above Fair Value Despite Positive Signals
Nov 26Increases to CEO Compensation Might Be Put On Hold For Now at The Clorox Company (NYSE:CLX)
Nov 14An Intrinsic Calculation For The Clorox Company (NYSE:CLX) Suggests It's 40% Undervalued
Oct 07Why We're Not Concerned About The Clorox Company's (NYSE:CLX) Share Price
Sep 21Clorox: If You Need FMCG Player In A Portfolio - Look Elsewhere
Sep 15Clorox (NYSE:CLX) Will Pay A Larger Dividend Than Last Year At $1.22
Aug 03Here's What To Make Of Clorox's (NYSE:CLX) Decelerating Rates Of Return
Jul 29Clorox: Stellar Delivery But Valuation Compression Has Some Distance To Go
Jul 29Clorox: Questionable Growth Target Puts Me On The Sidelines
Jul 17Clorox: Improving Outlook, Good Dividend Yield And Discounted Valuation
Jun 28Is Clorox (NYSE:CLX) A Risky Investment?
May 25We Like The Quality Of Clorox's (NYSE:CLX) Earnings
May 07Clorox (NYSE:CLX) Could Be At Risk Of Shrinking As A Company
Apr 26Colgate-Palmolive: Improved Financials To Navigate Headwinds (Rating Upgrade)
Apr 21Is There An Opportunity With The Clorox Company's (NYSE:CLX) 31% Undervaluation?
Apr 10Is Clorox (NYSE:CLX) Using Too Much Debt?
Feb 09Clorox: Relatively Overvalued And Headwinds Put Dividend At Risk
Feb 08The Clorox Company's (NYSE:CLX) Popularity With Investors Is Under Threat From Overpricing
Jan 25Is The Clorox Company (NYSE:CLX) Trading At A 27% Discount?
Jan 07Clorox: Not Wiped Out By Cyber Attack, Earnings And Revenue Need Cleaning Up
Jan 03Clorox: One Of The Best Household Product Portfolios
Dec 01Clorox: Undervalued But Too Many Red Flags
Oct 28Clorox: Cyberattack Compounds Existing Challenges
Oct 10Clorox: Still Struggling
Sep 25The Clorox Company: The Necessary Clean-Up Has Only Begun
Aug 30Despite Earnings Rally, Expectations On Clorox Are Low
Aug 15Clorox: Stable Growth Prospects But Pricey
Jul 20Keeping My Portfolio Clean By Avoiding Clorox
Jul 06Colgate-Palmolive: Stagnation And Debt-Fueled Dividends
Jun 01Clorox: Finally Emerging From The Pandemic Shadows
Feb 21Financial Position Analysis
Short Term Liabilities: CLX's short term assets ($1.6B) do not cover its short term liabilities ($1.6B).
Long Term Liabilities: CLX's short term assets ($1.6B) do not cover its long term liabilities ($3.7B).
Debt to Equity History and Analysis
Debt Level: CLX's net debt to equity ratio (985.7%) is considered high.
Reducing Debt: CLX's debt to equity ratio has increased from 497.5% to 1109.8% over the past 5 years.
Debt Coverage: CLX's debt is well covered by operating cash flow (36%).
Interest Coverage: CLX's interest payments on its debt are well covered by EBIT (17.2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 00:32 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
The Clorox Company is covered by 43 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Staszak | Argus Research Company |
| Edward Lewis | Atlantic Equities LLP |
| Ishan Majumdar | Baptista Research |